This article is more than 5 years old. Information may no longer be current.

AACE highlights include new therapies for diabetes, secondary hypogonadism, obesity

As a service to its readers, Healio Internal Medicine presents the top five news articles from the 2017 American Association of Clinical Endocrinologists (AACE) Annual Scientific and Clinical Congress, in Austin, Texas, including research in topics such as secondary hypogonadism, type 2 diabetes, obesity, as well as glycemic management and treatment options for patients with diabetes and heart failure.

Diabetes data downloads offer important keys to glycemic management

Downloaded data from diabetes devices can offer clinicians the missing clues needed to better understand why a patient has poor glycemic control; however, many clinicians are not reviewing these data due to time and cost concerns, Irl Hirsch, MD, said during a presentation. Read More.

New therapies offer options for patients with diabetes, heart failure

New anti-diabetic therapies offer options for patients with type 2 diabetes and heart failure, whereas several ongoing and longer-term studies are shedding new light on more controversial agents for this patient population, according to Richard Gilbert, MD, PhD, FRCPC. Read More.

Testosterone replacement therapy lowers mortality, CV risk in secondary hypogonadism

Testosterone replacement therapy may lower the risk for myocardial infarction, stroke and all-cause mortality in men with secondary hypogonadism. Read More.

Canagliflozin improves adipose tissue function in type 2 diabetes

In adults with type 2 diabetes, the SGLT2 inhibitor canagliflozin improved adipose tissue function, independent of weight loss, when compared with glimepiride therapy for 52 weeks, W. Timothy Garvey, MD, FACE, said during a presentation. Read More.

Phentermine lowers weight, systolic BP in adults with obesity

Adults with obesity assigned to treatment with phentermine for 6 months experienced weight loss and decreases in diastolic and systolic BP, but BP did not change in those with diabetes, according to findings presented. Read More.

For all of Healio’s coverage of the AACE meeting, visit the meeting news center.